GERN vs HELP: stock comparison and AI forecast
Geron Corp (GERN) and Helus Pharma Inc. (HELP) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
GERN Geron Corp
- Market Cap
- $610M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
HELP Helus Pharma Inc.
- Market Cap
- $613M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- GERN and HELP have similar market capitalizations ($610M and $613M).
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | GERN | HELP |
|---|---|---|
| Market Cap | $610M | $613M |
| P/B Ratio | 2.69x | – |
| EPS | $-0.10 | – |
| Book Value/Share | $0.35 | – |
Profitability & Margins
| Metric | GERN | HELP |
|---|---|---|
| ROE | -37.6% | – |
| ROA | -16.2% | – |
| ROIC | -7.1% | – |
| Operating Margin | -15.6% | – |
| Net Margin | -41.1% | – |
| EBT Margin | -22.6% | – |
Financial Health
| Metric | GERN | HELP |
|---|---|---|
| Current Ratio | 6.31x | – |
| Quick Ratio | 4.61x | – |
| D/E Ratio | 1.33x | – |
| Financial Leverage | 2.33x | – |
| Interest Coverage | -2.2x | – |
| Working Capital | $394M | – |
Cash Flow
| Metric | GERN | HELP |
|---|---|---|
| Operating Cash Flow | -$91M | – |
Income Statement
| Metric | GERN | HELP |
|---|---|---|
| Operating Income | -$32M | – |
| Net Income | -$85M | – |
| R&D Expense | $63M | – |
| SG&A Expense | $152M | – |
Dividend & Shareholder Information
| Metric | GERN | HELP |
|---|---|---|
| Shares Outstanding | 642M | 73M |
GERN vs HELP: stock comparison and AI forecast
Which is bigger, GERN or HELP?
GERN and HELP have similar market capitalizations ($610M and $613M).
Which one does Intratio's AI model rank higher, GERN or HELP?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.